Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Company Overview
Varex Imaging Corp is the world's largest independent supplier of x-ray imaging components, offering innovative solutions in both the medical imaging and industrial x-ray systems sectors. Specializing in the design and manufacture of high-quality x-ray tubes, digital detectors, and comprehensive image processing systems, Varex Imaging plays a pivotal role in enabling accurate diagnostics and effective security measures across various industries.
Core Business and Product Portfolio
The company operates through two primary segments. In the Medical Segment, Varex Imaging focuses on the development, production, and service of components critical for diagnostic processes. This includes a full suite of products such as x-ray tubes, digital detectors, generators, and accessories that consistently meet rigorous performance and safety standards demanded by modern healthcare diagnostics. Equally important is the Industrial Segment, where the company designs and manufactures advanced imaging solutions like Linatron x-ray accelerators, digital flat panel detectors, and high-voltage connectors. These products facilitate essential functions in security screening, industrial inspection, and non-destructive testing while ensuring precise and reliable operation.
Market Position and Global Reach
Varex Imaging has established a strong global presence, with a dominant market share in regions including Europe, the Middle East, and Africa (EMEA), complemented by robust activities in the Americas and Asia Pacific. This widespread reach underscores the company's ability to adapt to diverse regulatory frameworks and meet varying customer requirements across different geographies. The firm's dependable quality and continual innovation have solidified its position as a go-to provider for equipment manufacturers seeking bespoke x-ray imaging solutions.
Technological Innovation and Quality Control
Central to Varex Imaging's operations is a commitment to technological excellence. The company employs advanced engineering techniques and stringent quality control protocols to ensure that every component complies with high-performance standards. Its innovative approach is manifested in the extensive catalog of precision-engineered products that are integral to both diagnostic imaging and security screening. This focus on continuous improvement is supported by substantial research and development efforts aimed at enhancing product efficiency, safety, and reliability.
Operational Excellence and Strategic Differentiation
The company's operational strategy hinges on a deep understanding of industry dynamics. Its product portfolio, marked by technological superiority and an emphasis on customized solutions, sets it apart in a competitive market. Whether catering to the complex demands of modern healthcare diagnostics or addressing the rigorous requirements of industrial inspection systems, Varex Imaging maintains a steadfast commitment to quality and innovation. This dedication not only supports the success of its customers but also reinforces the firm's reputation for delivering robust and high-performance imaging components.
Industry Keywords and Expert Terminology
From the outset, key industry terms like "x-ray imaging components," "medical imaging solutions," and "industrial x-ray systems" underscore the company's expertise. By integrating such terms naturally into the content, the description demonstrates a high level of industry insight and technical proficiency, ensuring that both new and seasoned investors alike gain a clear perspective on the company's operations.
Conclusion
In summary, Varex Imaging Corp stands as an essential contributor to the x-ray imaging sector, with a diverse product offering that spans both medical and industrial applications. Its strategic approach, underpinned by innovative R&D and rigorous quality controls, has enabled the company to maintain its competitive edge in a global marketplace. For anyone seeking a detailed analysis of a firm that underpins vital diagnostic and security imaging technologies, Varex Imaging represents a comprehensive study in precision engineering and operational excellence.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q2 of fiscal 2023 on May 2, 2023, after market close. A conference call will follow at 3:00 pm Mountain Time, and interested parties can listen live via the company’s website or by phone. The conference call will be archived for future access.
Varex specializes in X-ray imaging components including tubes and digital detectors, servicing the medical, industrial, and security sectors. Headquartered in Salt Lake City, Utah, Varex employs around 2,400 personnel across North America, Europe, and Asia.
Varex Imaging Corporation (Nasdaq: VREX) announced upcoming presentations at two virtual investor conferences. The presentations will be held at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 12:40 pm ET, and the Sidoti Small-Cap Conference on March 23, 2023, at 2:30 pm ET. Both events will be available via live webcast on Varex’s website, with replays accessible for 90 days post-event. Varex is a leading manufacturer of X-ray imaging components used in various applications, employing around 2,300 people globally.
Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q1 FY23. Revenues reached $206 million, reflecting an 11% sequential decline but a 3% year-over-year increase. The GAAP gross margin was 31%, while the non-GAAP gross margin stood at 32%. Operating expenses were $50 million (GAAP) and $47 million (non-GAAP). The GAAP net earnings were $0.08 per diluted share, down from $0.42 last quarter, with non-GAAP EPS at $0.21. The company anticipates Q2 revenues between $205 million and $225 million and non-GAAP EPS between $0.05 and $0.25.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q1 FY 2023 on January 31, 2023, after regular trading hours. A conference call will follow at 3:00 PM MT, accessible via the company's website or by phone. The replay will be available until February 14, 2023. Varex is a leader in X-ray imaging components, serving various applications in medical, industrial, and security sectors. Employing approximately 2,300 people globally, the company has a rich history of innovation in imaging technologies.
Varex Imaging Corporation (Nasdaq: VREX) will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference on Wednesday, January 11, 2023, at 3:45 PM ET. The presentation will be given by the Chief Financial Officer, Sam Maheshwari, and will provide an overview of the company’s business. The event will be accessible via a listen-only webcast and will be available for replay for 90 days at vareximaging.com.
Varex Imaging Corporation (NASDAQ: VREX) has announced its 2023 Annual Meeting of Stockholders will take place virtually on February 9, 2023, at 5:30 pm Mountain Time. The board believes this format increases participation, cuts costs, and ensures health safety. Stockholders who were on record by the close of business on December 12, 2022, can vote on meeting matters. Varex will provide essential details and encourages stockholders to vote and submit proxies in advance.
Varex Imaging Corporation (Nasdaq: VREX) reported record Q4 FY22 revenues of $231 million, with a GAAP gross margin of 32% and a non-GAAP operating margin of 13%. For FY22, total revenues reached $859 million, marking a 10% operating margin. Q4 earnings were $0.32 GAAP and $0.42 non-GAAP per diluted share. Despite supply chain challenges, the company saw an 8% sequential revenue increase driven by growth in Medical and Industrial segments. For Q1 FY23, Varex expects revenues between $195 million and $215 million.
Varex Imaging Corporation (Nasdaq: VREX) announced it will release unaudited financial results for Q4 and fiscal year 2022 after market close on November 15, 2022. A conference call will follow at 3:00 pm MT, available via webcast on the company's website. Varex specializes in X-ray imaging components, including tubes and digital detectors, utilized in medical and security sectors. With over 2,100 employees globally, Varex continues its 70+ year history of innovation in the imaging industry.
FAQ
What is the current stock price of Varex Imaging (VREX)?
What is the market cap of Varex Imaging (VREX)?
What is the primary focus of Varex Imaging Corp?
Which business segments does Varex Imaging operate in?
What types of products does the Medical Segment provide?
How does Varex Imaging support industrial imaging applications?
In which regions does Varex Imaging have significant market reach?
How does the company ensure product quality and reliability?
What distinguishes Varex Imaging from its competitors?
How important is technological innovation to Varex Imaging?
